SMTL ID : 7nqw.1

Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.78 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: Y.195, R.199, R.202, Y.241 4 PLIP interactions: 4 interactions with chain A Water bridges: A:Y.241, A:Y.241 Salt bridges: A:R.199, A:R.202 SO4.2: 1 residues within 4Å: Chain A: R.199 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.199

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.3: 4 residues within 4Å: Chain A: K.159, S.161, T.198 Ligands: DMS.4 No protein-ligand interaction detected (PLIP) DMS.4: 6 residues within 4Å: Chain A: S.161, N.162, C.174, D.175 Ligands: DMS.3, UNW.5 2 PLIP interactions: 2 interactions with chain A Water bridges: A:K.159 Salt bridges: A:D.175

1 x UNW: 6-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-2-[2-oxidanylidene-2-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)ethyl]-3~{H}-isoindol-1-one(Non-covalent)

UNW.5: 24 residues within 4Å: Chain A: I.39, A.43, Y.44, V.47, A.60, K.62, I.64, Y.72, R.75, T.76, E.79, Q.113, D.114, L.115, M.116, E.117, T.118, D.119, K.122, L.164, C.174, D.175, G.177 Ligands: DMS.4 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.39, A:Y.44, A:V.47, A:V.47, A:Y.72, A:R.75, A:L.164 Hydrogen bonds: A:M.116, A:M.116, A:K.122, A:D.175 Water bridges: A:K.62 pi-Stacking: A:Y.44 Halogen bonds: A:Q.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heightman, T.D. et al., Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J.Med.Chem. (2021)

Release Date

2021-10-06

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence